Cost effectiveness of benralizumab for severe, uncontrolled oral corticosteroid-dependent asthma in Sweden.

Maria Andersson,Christer Janson,Thomas Kristensen,Agota Szende,Sarowar Golam

Cost effectiveness of benralizumab for severe, uncontrolled oral corticosteroid-dependent asthma in Sweden.

2020

Maria Andersson
Christer Janson
Thomas Kristensen
Agota Szende
Sarowar Golam

Aim: We investigated cost effectiveness of benralizumab vs. standard of care (SOC) plus oral corticosteroids (OCS) for patients with severe, eosinophilic OCS-dependent asthma in Sweden.Materials an...

Keywords:

Asthma
standard of care
Cost-effectiveness analysis
Intensive care medicine
Medicine
Corticosteroid
cost effectiveness
severe asthma
Eosinophilic
Benralizumab

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations